3/4/2025HighTide Thera Publishes Positive Phase 2 Data on HTD1801 for Type 2 D...

3/4/2025Insilico and Tenacia Announce Research Collaboration for CNS Drug Disc...

3/4/2025Amoytop's Strategic Acquisition of Skyline Assets Marks Expansion into...

3/4/2025Raziel and Fosun's JuveStar Launch Phase 3 Trial in China for RZL-012

3/3/2025Innovent's IBI363 Enters Pivotal Trial, Challenging Keytruda in Melano...

2/28/2025SciClone Secures Rights to Eisai's Tasurgratinib for Greater China

2/28/2025Henlius Initiates Phase 1b/2 Trial for PD-L1 ADC HLX43 in Solid Tumors

2/28/2025Recent Executive Moves

2/28/2025CDE Seeks Public Feedback on "SPARK Initiative" to Boost Pediatric Onc...

2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...

2/28/2025Duality Biologics Withdraws Hong Kong IPO Plans Amidst Strategic Partn...

2/27/2025Takeda Expands Partnership with BridGene to Tackle Hard-to-Drug Target...

2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA

2/27/2025Akeso Initiates First-in-Human Phase 1 Trial for HER3-Targeting ADC AK...

2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...

2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars

2/27/2025HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies

2/27/2025IVIEW Thera Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic...

2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...

2/26/2025YolTech Therapeutics Announces Positive Clinical Data for In Vivo Gene...

2/26/2025Former NMPA Deputy Commissioner Under Investigation

2/26/2025In Vivo Gene Editing Product ART002 Achieves Saturation of Pharmacolog...

2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial

2/25/2025Ardelyx/Fosun'sTenapanor Approved for Hyperphosphatemia in CKD Dialysi...

2/25/2025China Launches Flagship Hospital Alliance to Advance Integrative Medic...

2/25/2025OS Therapies Launches Subsidiary to Seek ADC Joint Ventures in US and ...

2/25/2025Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...

2/25/2025Innovent's Dual Immunotherapy for Colon Cancer Advances with NMPA Prio...

2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...

2/21/2025Recent Executive Moves

Page:20/53 Total number of articles:1564: [First][<<] [18] [19] [20] [21] [22] [>>] [End]